Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
Details for Australian Patent Application No. 2003243139 (hide)
International Classifications
Event Publications
11 September 2003 Complete Application Filed
Priority application(s): 60/370,407 05.04.02 US
4 December 2003 Application Open to Public Inspection
Published as AU-B-2003243139
27 April 2006 Change of Name(s) of Applicant(s), Section 104
Amgen Inc., Has no value - Entry Incomplete The name of the applicant has been changed to Amgen Inc.; Medarex, Inc.
21 June 2007 Application Accepted
Published as AU-B-2003243139
18 October 2007 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003243140-METHODS AND SYSTEMS FOR MODELING MATERIAL BEHAVIOR
2003243138-Activation of tumor-reactive lymphocytes via antibodies or genes recognizing CD3 or 4-1BB
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser